InCann

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameInCann
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid modulators
TargetsUpdating
Therapy Area/IndicationsIrritable Bowel SyndromeCrohn DiseaseColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRoyal Melbourne Intitute of Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoyal Melbourne Intitute of TechnologyMGC Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsIrritable Bowel SyndromeCrohn DiseaseColitis

Other Information

ATC CodeN/A
Related LinksN/A